Atovaquone Suspension
Product Images NDC 73141-104

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Atovaquone (NDC 73141-104). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A2a Integrated Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atovaquone Foil Label (A2a Atovaquone 05ml Foil Final 11 4 24 Jpg)

This is a prescription oral suspension of Atovaquone with a concentration of 750mg/5mL. It is recommended to shake gently before using. The product is only for institutional use and should be stored at a temperature between 59°F to 86°F. Distributed by A2A Integrated Pharmaceuticals in Bowling Green, KY.*

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.